Smith, L., Mosley, J., Yates, J., & Caswell, L. (2016). The New Face of Hyperlipidemia Management: Proprotein Convertase Subtilisin/Kexin Inhibitors (PCSK-9) and Their Emergent Role As An Alternative To Statin Therapy. Journal of Pharmacy & Pharmaceutical Sciences, 19(1), 137–146. https://doi.org/10.18433/J3J02P